⌘K

Login Start Free

Home/Filings/4/0000950172-24-000139

4//SEC Filing

Sollis Gary 4

Accession 0000950172-24-000139

CIK 0001633932other

View on SEC.gov Company Profile

Filed

Mar 27, 8:00 PM ET

Accepted

Mar 28, 12:39 PM ET

Size

4.8 KB

Accession

0000950172-24-000139

Insider Transaction Report

Form 4

Period: 2024-03-25

ESSA Pharma Inc.EPIX

Director

Transactions

Award
Options
2024-03-25+50,000→ 50,000 total
Exercise: $9.04From: 2025-03-25Exp: 2034-03-25→ Common Shares (50,000 underlying)

Documents

1 file

4
form4.xmlPrimary

Issuer

ESSA Pharma Inc.

CIK 0001633932

Entity typeother

Related Parties

1

filerCIK 0001826324

Filing Metadata

Form type: 4
Filed: Mar 27, 8:00 PM ET
Accepted: Mar 28, 12:39 PM ET
Size: 4.8 KB

View on SEC.gov